These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 1488561

  • 1. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
    Sovijärvi AR, Reinikainen K, Freudenthal Y, Andersson P, Riska H.
    Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
    Aalbers R, Boorsma M, van der Woude HJ, Jonkers RE.
    Respir Res; 2010 May 28; 11(1):66. PubMed ID: 20509942
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.
    Maesen FP, Smeets JJ, Gubbelmans HL, Zweers PG.
    Chest; 1990 Mar 28; 97(3):590-4. PubMed ID: 1968371
    [Abstract] [Full Text] [Related]

  • 7. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
    Boner AL, Spezia E, Piovesan P, Chiocca E, Maiocchi G.
    Am J Respir Crit Care Med; 1994 Apr 28; 149(4 Pt 1):935-9. PubMed ID: 7908246
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol.
    Shapiro GS, Yegen U, Xiang J, Kottakis J, Della Cioppa G.
    Clin Ther; 2002 Dec 28; 24(12):2077-87. PubMed ID: 12581546
    [Abstract] [Full Text] [Related]

  • 11. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
    Löfdahl CG, Svedmyr N.
    Allergy; 1989 May 28; 44(4):264-71. PubMed ID: 2544117
    [Abstract] [Full Text] [Related]

  • 12. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
    Wallin A, Sandström T, Rosenhall L, Melander B.
    Thorax; 1993 Jun 28; 48(6):611-4. PubMed ID: 8346490
    [Abstract] [Full Text] [Related]

  • 13. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
    Becker AB, Simons FE.
    J Allergy Clin Immunol; 1989 Dec 28; 84(6 Pt 1):891-5. PubMed ID: 2574732
    [Abstract] [Full Text] [Related]

  • 14. Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction.
    Malo JL, Cartier A, Trudeau C, Ghezzo H, Gontovnick L.
    Am Rev Respir Dis; 1990 Nov 28; 142(5):1147-52. PubMed ID: 1978619
    [Abstract] [Full Text] [Related]

  • 15. Inhaled formoterol dry powder in the treatment of patients with reversible obstructive airway disease. A 3-month, placebo-controlled comparison of the efficacy and safety of formoterol and salbutamol, followed by a 12-month trial with formoterol.
    Steffensen I, Faurschou P, Riska H, Rostrup J, Wegener T.
    Allergy; 1995 Aug 28; 50(8):657-63. PubMed ID: 7503401
    [Abstract] [Full Text] [Related]

  • 16. Prophylaxis of exercise-induced asthma with inhaled formoterol, a long-acting beta 2-adrenergic agonist.
    McAlpine LG, Thomson NC.
    Respir Med; 1990 Jul 28; 84(4):293-5. PubMed ID: 2236756
    [Abstract] [Full Text] [Related]

  • 17. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R.
    Pulm Pharmacol Ther; 2004 Jul 28; 17(2):89-95. PubMed ID: 15123230
    [Abstract] [Full Text] [Related]

  • 18. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.
    Wallin A, Melander B, Rosenhall L, Sandström T, Wåhlander L.
    Thorax; 1990 Apr 28; 45(4):259-61. PubMed ID: 1972599
    [Abstract] [Full Text] [Related]

  • 19. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I, Hall IP, McFarlane LC, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Mar 28; 101(3):337-41. PubMed ID: 9525449
    [Abstract] [Full Text] [Related]

  • 20. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
    Arvidsson P, Larsson S, Löfdahl CG, Melander B, Svedmyr N, Wåhlander L.
    Eur Respir J; 1991 Nov 28; 4(10):1168-73. PubMed ID: 1687129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.